Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
U.S. nonfarm payrolls rose by 115,000 in April, outpacing forecasts, while the unemployment rate remained at 4.3%. The data supported market expectations that the Federal Reserve will keep interest rates steady after its recent decision to hold the policy rate in the 3.50%-3.75% range. Stocks advanced, Treasury yields declined, and the dollar weake…
Paul Christopher Baker, the Chief Operating Officer of Kopin Corp (NASDAQ:KOPN), has completed a sale of company common stock totaling $288,801. The transaction, which occurred on May 6, 2026, involved the disposal of 58,939 shares at a price point of $4.90 per share. This divestment comes at a time when Kopin Corp's stock is trading near its 52-we…
ENvue Medical announced that the USPTO has issued a Notice of Allowance for a patent covering its novel drug delivery system that uses proprietary surface acoustic wave (SAW) ultrasound technology to enhance transdermal delivery of cannabinoid-based therapeutics. The patent covers multiple components of the combined SAW ultrasound and cannabinoid t…
Trinity Capital is trading near $17.16 with a monthly cash distribution of $0.17 (annualized $2.04) and a market cap around $1.54B. Strong ROE (~12.4%), a P/E near 9, and consistent dividend history make TRIN a pragmatic income compounder. I recommend a tactical long with an entry at $17.20, stop at $16.00 and target at $20.00 over a long-term (180…
U.S. interest rate futures moved to scale back the likelihood of a year-end Federal Reserve rate increase and raised the odds the central bank will hold policy steady, following April's stronger-than-expected job gains. The market now prices a much lower chance of a December hike and a higher probability of no change at that meeting, after a govern…
Alpha Tau Medical announced a conference call scheduled for May 11, 2026, to discuss interim clinical results from the first three patients treated with its alpha-radiation therapy Alpha DaRT in a U.S. trial for recurrent glioblastoma. The trial aims to evaluate the safety and feasibility of the treatment in up to ten patients with inoperable recur…
IP Strategy Holdings, Inc. announced the early access launch of Numo, a consumer app developed by Poseidon for collecting real-world, rights-cleared AI training data. By incentivizing users to contribute voice recordings across underrepresented languages and embedding licensing and provenance on-chain through the Story blockchain, Numo addresses a …
Insider filings disclosed on Thursday, May 7, 2026, show a mix of large purchases and sizeable dispositions across U.S. public markets. The most notable buy: Tether Global Investments Fund and affiliated parties acquired 530,338 shares of Gold.com at $44.50 per share on May 5, 2026, a transaction valued at roughly $23.6 million and representing the…
Royal Philips announced that its shareholders approved all proposals at the Annual General Meeting (AGM) 2026, including the appointment of John DeFord to the Supervisory Board, re-appointments of key board members including CEO Roy Jakobs, and discharge of board members. The company maintains strong leadership continuity and expresses confidence i…
Embecta Corp., a global medical supplies company focused on insulin delivery innovations, announced its upcoming presentation at the 2026 BofA Securities Global Health Care Conference in Las Vegas on May 13, 2026. The company's management will discuss its current initiatives and future outlook, with a live webcast available for investors.
BioAge Labs announced positive Phase 1 topline data for BGE-102, an oral NLRP3 inhibitor showing significant reductions in inflammatory biomarkers related to cardiovascular risk. The company plans to initiate Phase 2 cardiovascular and Phase 1b/2a diabetic macular edema (DME) proof-of-concept trials in mid-2026, supported by $132.3 million gross pr…
E-Power Inc. announced that its subsidiary, Sunrise New Energy, received a $294,000 grant from the Guizhou Provincial Development and Reform Commission to support the establishment of the Guizhou Carbon-Based Anode Material Industrial Technology Engineering Center. This initiative aims to foster collaboration and innovation in battery anode materia…
J-Star Holding announced signing a non-binding MOU with Singapore-based White Group to advance capital formation for a $100 million automated solid-state battery production facility in Baytown, Texas. This initiative builds on existing partnerships and grant applications aimed at producing 100 MWh modular battery lines targeting UAV and drone marke…
Vivakor, Inc. has completed a $12 million private placement of six-month convertible promissory notes with institutional investors. The proceeds will be used to reduce outstanding debt, support working capital, advance the commissioning of its Remediation Processing Center in Houston, and execute its integrated infrastructure and commercial platfor…
Verizon Communications Inc. announced that CEO Dan Schulman will speak at two prominent investor conferences in May 2026 — the MoffettNathanson Media, Internet & Communications Conference and the J.P. Morgan Global Technology, Media, and Communications Conference. Both sessions will be webcast and available to investors via Verizon's investor relat…
United-Guardian, Inc. (NASDAQ:UG) announced robust financial results for Q1 2026, with sales rising to $2.87 million from $2.48 million in the previous year and net income increasing to $818,902 from $560,895. Growth was mainly driven by a 24% increase in pharmaceutical sales, particularly Renacidin®, and a 21% rise in cosmetic ingredient sales, su…
Alpha Tau Medical Ltd. has completed enrollment of all 88 patients in its ReSTART pivotal U.S. clinical trial evaluating its novel alpha-radiation therapy, Alpha DaRT, for recurrent cutaneous squamous cell carcinoma (cSCC). This milestone marks a critical step toward potential FDA pre-market approval (PMA), building on previous clinical evidence fr…
Wingstop is trading well below its 2025 highs as same-store traffic softens, but the company continues to post durable system-wide sales growth, strong adjusted EBITDA expansion and aggressive unit growth. This trade targets a mid-term recovery as unit economics and Smart Kitchen efficiency start to show through to margins.
European Wax Center, Inc., a leading U.S. franchisor and operator of out-of-home waxing services, has completed its take-private transaction by General Atlantic for an enterprise value of approximately $640 million. This transaction involved General Atlantic acquiring all remaining outstanding shares, leading to the delisting of European Wax Center…
Global equity funds posted net inflows for a seventh consecutive week through May 6, driven by better-than-expected first-quarter corporate earnings and strength in technology stocks. While total equity fund purchases slowed to the smallest weekly addition since March 18, bond and money-market instruments saw substantial demand, and flows differed …
Planet Fitness saw its stock ratings and price targets cut by Morgan Stanley and Bank of America after the gym operator reported softer membership trends, abandoned a planned Black Card price increase and initiated a marketing overhaul. Management trimmed full-year 2026 guidance across same-club sales, revenue and EPS, prompting concern from analys…
Nvidia's recent strategic moves - a roughly $2B cloud/data-center equity bet and a separate $3.4B managed GPU services contract - materially shorten the path from chips to recurring revenue. The market already prices high growth into the stock (market cap > $5T, P/E ~43), but near-term fundamental and technical momentum supports a mid-term long tra…
Allarity Therapeutics announced that CEO Thomas Jensen will present at Precision Medicine Forum Europe 2026 on their investigational drug stenoparib, a dual PARP and WNT pathway inhibitor in Phase 2 trials for ovarian and small cell lung cancers. The presentation will highlight the drug's unique mechanism and the company's predictive biomarker, the…
Moleculin Biotech, Inc. has secured an additional patent in Hong Kong for its liposomal Annamycin formulation, extending intellectual property protection through 2040. This milestone enhances the company's global exclusivity strategy as it approaches the release of Phase 3 clinical data for Annamycin, a lead oncology drug candidate. The patent comp…
HSBC recorded an unexpected $400 million loss tied to a fraud case involving a British mortgage lender, focusing attention on the complex and sometimes opaque ties between banks and the $3.5 trillion private credit market. Global regulators have flagged rising risks from banks' growing exposure to private credit, while asset managers and funds have…
